20. March 2020
Renewed presidency in the Austrian Biosimilar Association

Sabine Möritz-Kaisergruber, President of the Austrian Biosimilar Association (BiVÖ) is pleased about the appointment of Dr. Gabriele Hartl, Head of the Oncology Business Unit at Amgen as the new Vice President of the BiVÖ.

“With Gabriele Hartl, I have a further expert on biosimilars by my side. She can actively provide information about the role of biosimilars in a sustainably financed health care system. I am looking forward to a great cooperation!”